benoxathian and oxidopamine

benoxathian has been researched along with oxidopamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brown, CH; Bull, PM; Leng, G; Ludwig, M; Munro, G; Murphy, NP; Russell, JA	1

Other Studies

1 other study(ies) available for benoxathian and oxidopamine

Article	Year
Interruption of central noradrenergic pathways and morphine withdrawal excitation of oxytocin neurones in the rat. The Journal of physiology, 1998, Mar-15, Volume: 507 ( Pt 3) Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Cerebral Ventricles; Cholecystokinin; Electrophysiology; Female; Hypothalamus; Infusions, Parenteral; Morphine; Morphine Dependence; Naloxone; Neurons; Norepinephrine; Oxathiins; Oxidopamine; Oxytocin; Pituitary Gland; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Substance Withdrawal Syndrome; Supraoptic Nucleus	1998

Article

Year

Interruption of central noradrenergic pathways and morphine withdrawal excitation of oxytocin neurones in the rat.

The Journal of physiology, 1998, Mar-15, Volume: 507 ( Pt 3)

Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Cerebral Ventricles; Cholecystokinin; Electrophysiology; Female; Hypothalamus; Infusions, Parenteral; Morphine; Morphine Dependence; Naloxone; Neurons; Norepinephrine; Oxathiins; Oxidopamine; Oxytocin; Pituitary Gland; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Substance Withdrawal Syndrome; Supraoptic Nucleus

1998